XML 79 R64.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2026
Oct. 31, 2025
Jul. 31, 2025
Jan. 31, 2025
Oct. 31, 2024
Jul. 31, 2024
Jan. 31, 2026
Jan. 31, 2025
Apr. 30, 2025
Segment Reporting Information [Line Items]                  
Net sales $ 69,399     $ 67,167     $ 210,599 $ 163,324  
Intersegment revenues 0     0     0 0  
Depreciation and amortization 1,597     1,563     4,726 3,184  
Interest expense 1,112     1,137     3,231 2,051  
Depreciation and amortization 1,604     1,275     8,977 7,636  
Income tax expense (benefit) 528     (108)     2,204 1,000  
Less: Net earnings attributable to the non-controlling interest 384     29     543 81  
Net earnings attributable to Kewaunee Scientific Corporation 692 $ 2,445 $ 3,093 1,354 $ 3,008 $ 2,193 6,230 6,555  
Segment assets 175,961     189,148     175,961 189,148 $ 194,654
Expenditures for segment assets 668     689     3,009 1,650  
Non-US                  
Segment Reporting Information [Line Items]                  
Net sales 22,693     18,428     59,804 43,617  
Operating Segments | Domestic Operations                  
Segment Reporting Information [Line Items]                  
Net sales 50,953     51,976     160,529 123,908  
Depreciation and amortization 1,479     1,414     4,366 2,736  
Interest expense 307     322     931 1,176  
Depreciation and amortization 2,312     3,514     13,091 12,914  
Income tax expense (benefit) 22     638     2,482 2,643  
Less: Net earnings attributable to the non-controlling interest 0     0     0 0  
Net earnings attributable to Kewaunee Scientific Corporation 2,290     2,876     10,609 10,271  
Segment assets 135,427     146,798     135,427 146,798  
Expenditures for segment assets 636     621     2,836 1,457  
Operating Segments | Domestic Operations | Non-US                  
Segment Reporting Information [Line Items]                  
Net sales 4,247     3,237     9,734 4,201  
Operating Segments | International Operations                  
Segment Reporting Information [Line Items]                  
Net sales 18,446     15,191     50,070 39,416  
Depreciation and amortization 97     107     292 317  
Interest expense 16     26     39 66  
Depreciation and amortization 2,351     786     4,518 2,183  
Income tax expense (benefit) 711     281     1,435 807  
Less: Net earnings attributable to the non-controlling interest 384     29     543 81  
Net earnings attributable to Kewaunee Scientific Corporation 1,256     476     2,540 1,295  
Segment assets 40,534     42,350     40,534 42,350  
Expenditures for segment assets 32     68     173 193  
Operating Segments | International Operations | Non-US                  
Segment Reporting Information [Line Items]                  
Net sales 18,446     15,191     50,070 39,416  
Segment Reporting, Reconciling Item, Corporate Nonsegment                  
Segment Reporting Information [Line Items]                  
Net sales 0     0     0 0  
Intersegment revenues (1,333)     (971)     (3,430) (3,064)  
Depreciation and amortization 21     42     68 131  
Interest expense 789     789     2,261 809  
Depreciation and amortization (3,059)     (3,025)     (8,632) (7,461)  
Income tax expense (benefit) (205)     (1,027)     (1,713) (2,450)  
Less: Net earnings attributable to the non-controlling interest 0     0     0 0  
Net earnings attributable to Kewaunee Scientific Corporation (2,854)     (1,998)     (6,919) (5,011)  
Segment assets 0     0     0 0  
Expenditures for segment assets 0     0     0 0  
Intersegment Eliminations | Domestic Operations                  
Segment Reporting Information [Line Items]                  
Intersegment revenues 463     28     869 298  
Intersegment Eliminations | International Operations                  
Segment Reporting Information [Line Items]                  
Intersegment revenues $ 870     $ 943     $ 2,561 $ 2,766